Drug Combination Details
General Information of the Combination (ID: C79198) | |||||
---|---|---|---|---|---|
Name | Gamma tocotrienol | + | Atorvastatin + Celecoxib | ||
Click to Show/Hide the Each NP or Drug Information of This Combination | |||||
Name | Gamma tocotrienol NP Info | Drug Info | |||
Structure |
![]() |
![]() |
|||
Name | Drug Info | ||||
Structure |
![]() |
![]() |
|||
Disease |
Colon cancer
[ICD-11: 2B90]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
|
Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
Biological
Regulation |
Induction | Cell cycle arrest in G0/G1 phase | ||||
Increase | DNA fragmentation | |||||
In-vitro Model | HT29 | CVCL_A8EZ | Colorectal adenocarcinoma | Mus musculus | ||
HCT 116 | CVCL_0291 | Colon carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Atorvastatin with gamma-tocotrienol and celecoxib exhibited a strong synergy against human colon cancer cells in causing cell cycle arrest and apoptosis. |
References | ||||
---|---|---|---|---|
Reference 1 | Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. Int J Cancer. 2010 Feb 15;126(4):852-63. |


